[Form 4] Global Medical REIT Inc. Insider Trading Activity

Rhea-AI Filing Summary

Global Medical REIT Inc. director Matthew Cypher purchased 1,350 shares of the company's common stock on 08/26/2025 at a price of $7.3781 per share. After the transaction he beneficially owns 1,350 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jamie Barber, on the same date.

Insights

Financial Analyst

TL;DR: Small insider purchase by a director; transaction size appears immaterial to valuation.

The purchase of 1,350 shares at $7.3781 is a routine insider buy disclosed on Form 4. Given the modest share count and absence of additional context such as total outstanding shares or recent trading volume in this filing, the transaction is unlikely to be material to company valuation by itself. It does, however, reflect a director-level purchase recorded under Section 16.

Corporate Governance Expert

TL;DR: Compliance disclosure executed properly; signature by attorney-in-fact documented.

The Form 4 identifies the reporting person as a director and reports a direct acquisition. The filing includes the required signature by an attorney-in-fact, indicating procedural compliance. There are no indications of rule 10b5-1 plan usage or other unusual reporting items in the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cypher Matthew

(Last) (First) (Middle)

7373 WISCONSIN AVENUE, SUITE 800

(Street)

BETHESDA MD 20814

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Global Medical REIT Inc. [ GMRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2025		P		1,350	A	$7.3781	1,350	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jamie Barber, as Attorney-in-Fact	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction is reported for GMRE on this Form 4?

The Form 4 reports that director Matthew Cypher purchased 1,350 shares of GMRE common stock on 08/26/2025 at $7.3781 per share.

How many shares does Matthew Cypher beneficially own after the transaction?

Following the reported purchase, Mr. Cypher beneficially owns 1,350 shares, held directly.

Was the Form 4 signed and who signed it?

The form was signed on 08/26/2025 by /s/ Jamie Barber, acting as attorney-in-fact.

Does the filing indicate use of a 10b5-1 trading plan?

No. The provided content does not indicate that the transaction was made pursuant to a Rule 10b5-1 trading plan.

Is the reported transaction a derivative or a non-derivative security?

The reported transaction is for common stock as a non-derivative security; no derivative transactions are reported in this Form 4.